Synonym(s)
HistoryThis section has been translated automatically.
DefinitionThis section has been translated automatically.
You might also be interested in
Occurrence/EpidemiologyThis section has been translated automatically.
Worldwide occurrence mainly among women of reproductive age. Estimated prevalence in women attending an STI clinic: 20-30%.
For women at higher risk of ST I, such as sex workers, the estimated prevalence is as high as 50-60% (Bautista Ct 2016)
The probability of developing bacterial vaginosis is higher if:
- a higher number of sexual partners is indicated
- for unmarried women
- in women who have had their first sexual intercourse at a very early age
- among sex workers
- for regularly performed vaginal showers
EtiopathogenesisThis section has been translated automatically.
Clinical featuresThis section has been translated automatically.
Vulvovaginitis and colpitis with low-viscosity, homogeneous, grey-white fluorine vaginalis. Characteristic, penetrating, fish-like odour (caused by various amines formed by the overgrowing anaerobes).
DiagnosisThis section has been translated automatically.
Diagnostic criteria (after Amsel 1983):
- Low-viscosity, homogeneous fluorine
- pH value > 4,5
- Fishy (amine) odor of vaginal secretion, which increases after addition of 10% potassium hydroxide
- "Cue cells" or " key cells " (vaginal epithelia covered with bacteria and characteristically spotted) with a proportion of >20% of epithelial cells
the diagnosis of bacterial vaginosis is considered confirmed if at least three of the four criteria listed are met.
Cult detection is not recommended for primary diagnosis (G. vaginalis selective agar; the basis of this is Columbia blood agar containing 5-10% rabbit blood or human blood).
External therapyThis section has been translated automatically.
Internal therapyThis section has been translated automatically.
Remember! In men Gardnerella vaginalis can persist asymptomatically in the urethra for months.
LiteratureThis section has been translated automatically.
- Blackbird R et al (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. At J Med 74: 18-22
- Bautista CT et al.(2016) Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res 3:4.
- Egan ME et al (2000) Diagnosis of vaginitis. On Fam Physician 62: 1095-1104
- Gardner HL, Dukes CD (1955) Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified "nonspecific" vaginitis. On J Obstet Gynecol 69: 962-976
- Guaschino S et al (2003) Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J Obstet Gynecol Reprod Biol 110: 149-152
- Hackel H et al. (1991) Importance of Gardnerella vaginalis culture in BV-score-secured bacterial vaginosis. dermatologist 42: 173-175
- Hartmann AA et al (1984) Gardnerella vaginalis infection-another STD. dermatologist 35: 512-516
- Lamont RF (2002) Antibiotics for the prevention of preterm birth. N Engl J Med 342: 581-583
- Leitich H (2003) Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. On J Obstet Gynecol 189: 139-147
- Manhart LE et al (2003) Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 187: 650-657
- Nelson DB et al (2003) Self-collected versus provider-collected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability. J Clin Epidemiol 56: 862-866
Incoming links (9)
Amine colpitis; Bacteriae; Candidiasis vulvovaginale; Gardnerella vaginalis infection; Povidone-iodine solution 10%.; Quinolinol sulphate monohydrate solution 0,1 % (nrf 11.127.); Vaginal fluoride; Vaginosis, bacterial; Vestibulitis, irritative;Outgoing links (7)
Columbia agar; Metronidazole; Povidone-iodine; Povidone-iodine solution 10%.; Tinidazole; Vaginal fluoride; Vaginosis, bacterial;Disclaimer
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.